Congruence Therapeutics Competitors and Similar CompaniesClear all

Congruence Therapeutics's competitors and similar companies include Kymera Therapeutics, Rubius Therapeutics, Adicet Bio and Aspen Neuroscience.

	Congruence Therapeutics Congruence Therapeutics (also known as Congruence Thérapeutique) is a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding.	Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.	Rubius Therapeutics Rubius is developing a new class of drugs, Red-Cell Therapeutics™.	Adicet Bio Adicet Bio is a biotechnology company that develops therapies for cancer diseases.	Aspen Neuroscience Aspen Neuroscience is a biotechnology company that focuses on cell therapies.
Founding Date	Founding Date 2021	Founding Date 2017	Founding Date 2013	Founding Date 2016	Founding Date 2018
Type	Type Private	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development machine learning therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy
Locations	Locations Montréal, CA HQ	Locations Watertown, US HQ Cambridge, US	Locations Cambridge, US HQ Smithfield, US	Locations Redwood City, US HQ Boston, US	Locations San Diego, US HQ
Employees	Employees 43	Employees 207	Employees 17423% increase	Employees 1438% increase	Employees 1236% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 3.1 b	Valuation ($) 7.5 m	Valuation ($) 116.2 m	Valuation ($) N/A
Financial
Net income	Net income N/A	Net income ($311.4m) (FY, 2025)	Net income ($179.7m) (FY, 2022)	Net income ($116.8m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 197m	Total funding raised $ 245m	Total funding raised $ 145.6m	Total funding raised $ 76.5m